Literature DB >> 27709237

Visual Impairment Screening at the Geriatric Frailty Clinic for Assessment of Frailty and Prevention of Disability at the Gérontopôle.

V Soler1, S Sourdet, L Balardy, G Abellan van Kan, D Brechemier, M E Rougé-Bugat, N Tavassoli, M Cassagne, F Malecaze, F Nourhashémi, B Vellas.   

Abstract

OBJECTIVES: To evaluate visual performance and factors associated with abnormal vision in patients screened for frailty at the Geriatric Frailty Clinic (GFC) for Assessment of Frailty and Prevention of Disability at Toulouse University Hospital.
DESIGN: Retrospective, observational cross-sectional, single-centre study.
SETTING: Institutional practice. PARTICIPANTS: Patients were screened for frailty during a single-day hospital stay between October 2011 and October 2014 (n = 1648). MEASUREMENTS: Collected medical records included sociodemographic data (including living environment and educational level), anthropometric data, and clinical data. The general evaluation included the patient's functional status using the Activities of Daily Living (ADL) scale and the Instrumental Activity of Daily Living (IADL) scale, the Mini-Mental State Examination (MMSE) for cognition testing, and the Short Physical Performance Battery (SPPB) for physical performance. We also examined Body Mass Index (BMI), the Mini-Nutritional Assessment (MNA), and the Hearing Handicap Inventory for the Elderly Screening (HHIE-S) tool. The ophthalmologic evaluation included assessing visual acuity using the Snellen decimal chart for distant vision, and the Parinaud chart for near vision. Patients were divided into groups based on normal distant/near vision (NDV and NNV groups) and abnormal distant/near vision (ADV and ANV groups). Abnormal distant or near vision was defined as visual acuity inferior to 20/40 or superior to a Parinaud score of 2, in at least one eye. Associations with frailty-associated factors were evaluated in both groups.
RESULTS: The mean age of the population was 82.6 ± 6.2 years. The gender distribution was 1,061 females (64.4%) and 587 males (35.6%). According to the Fried criteria, 619 patients (41.1%) were pre-frail and 771 (51.1%) were frail. Distant and near vision data were available for 1425 and 1426 patients, respectively. Distant vision was abnormal for 437 patients (30.7%). Near vision was abnormal for 199 patients (14%). Multiple regression analysis showed that abnormal distant vision as well as abnormal near vision were independently associated with greater age (P < 0.01), lower educational level (P < 0.05), lower performance on the MMSE (P < 0.001), and lower autonomy (P < 0.02), after controlling for age, gender, educational level, Fried criteria, and MMSE score.
CONCLUSION: The high prevalence of visual disorders observed in the study population and their association with lower autonomy and cognitive impairment emphasises the need for systematic screening of visual impairments in the elderly. Frailty was not found to be independently associated with abnormal vision.

Entities:  

Mesh:

Year:  2016        PMID: 27709237     DOI: 10.1007/s12603-015-0648-z

Source DB:  PubMed          Journal:  J Nutr Health Aging        ISSN: 1279-7707            Impact factor:   4.075


  46 in total

1.  Evaluation of complex activities in daily living of elderly Japanese with visual impairment.

Authors:  K Nakamura; A Otomo; A Maeda; S Kikuchi; Y Motohashi; M Tanaka; H Nakadaira; M Yamamoto
Journal:  Aging (Milano)       Date:  1999-04

2.  Depression and anxiety in visually impaired older people.

Authors:  Jennifer R Evans; Astrid E Fletcher; Richard P L Wormald
Journal:  Ophthalmology       Date:  2007-02       Impact factor: 12.079

3.  Inference comprehension during reading: influence of age and education in normal adults.

Authors:  Marcela Lima Silagi; Vivian Urbanejo Romero; Leticia Lessa Mansur; Marcia Radanovic
Journal:  Codas       Date:  2014 Sep-Oct

4.  Frailty Detection with the Gérontopôle Frailty Screening Tool (GFST).

Authors:  L Demougeot; G Abellan van Kan; B Vellas; P de Souto Barreto
Journal:  J Frailty Aging       Date:  2013

5.  How to improve screening for diabetic retinopathy: the Burgundy experience.

Authors:  C Creuzot-Garcher; L Malvitte; A C Sicard; A Guillaubey; A Charles; J N Beiss; A Bron
Journal:  Diabetes Metab       Date:  2010-01-29       Impact factor: 6.041

6.  Frailty in older adults: evidence for a phenotype.

Authors:  L P Fried; C M Tangen; J Walston; A B Newman; C Hirsch; J Gottdiener; T Seeman; R Tracy; W J Kop; G Burke; M A McBurnie
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2001-03       Impact factor: 6.053

7.  Visual impairment in a Taiwanese population: prevalence, causes, and socioeconomic factors.

Authors:  J H Liu; C Y Cheng; S J Chen; F L Lee
Journal:  Ophthalmic Epidemiol       Date:  2001-12       Impact factor: 1.648

8.  Providing instrumental social support is more beneficial to reduce mortality risk among the elderly with low educational level in Taiwan: a 12-year follow-up national longitudinal study.

Authors:  C C Liao; C J Yeh; S H Lee; W C Liao; M Y Liao; M C Lee
Journal:  J Nutr Health Aging       Date:  2015-04       Impact factor: 4.075

9.  Frailty in older persons: multisystem risk factors and the Frailty Risk Index (FRI).

Authors:  Tze Pin Ng; Liang Feng; Ma Shwe Zin Nyunt; Anis Larbi; Keng Bee Yap
Journal:  J Am Med Dir Assoc       Date:  2014-04-17       Impact factor: 4.669

10.  Evaluation of non-medical costs associated with visual impairment in four European countries: France, Italy, Germany and the UK.

Authors:  Antoine Lafuma; Antoine Brézin; Stefania Lopatriello; Klaus Hieke; Julia Hutchinson; Viviane Mimaud; Gilles Berdeaux
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

View more
  8 in total

1.  Near Vision Impairment and Frailty: Evidence of an Association.

Authors:  Varshini Varadaraj; Moon Jeong Lee; Jing Tian; Pradeep Y Ramulu; Karen Bandeen-Roche; Bonnielin K Swenor
Journal:  Am J Ophthalmol       Date:  2019-08-26       Impact factor: 5.258

2.  Decline in Instrumental Activities of Daily Living over 4-Year: The Association with Hearing, Visual and Dual Sensory Impairments among Non-Institutionalized Women.

Authors:  N Bouscaren; H Yildiz; L Dartois; M N Vercambre; M C Boutron-Ruault
Journal:  J Nutr Health Aging       Date:  2019       Impact factor: 4.075

3.  Editorial: Involving Primary Care Health Professionals in Geriatric Assessment.

Authors:  B Fougère; M Cesari; H Arai; J Woo; R A Merchant; L Flicker; A Cherubini; J M Bauer; B Vellas; J E Morley
Journal:  J Nutr Health Aging       Date:  2018       Impact factor: 4.075

4.  Vision impairment and cognitive decline among older adults: a systematic review.

Authors:  Niranjani Nagarajan; Lama Assi; V Varadaraj; Mina Motaghi; Yi Sun; Elizabeth Couser; Joshua R Ehrlich; Heather Whitson; Bonnielin K Swenor
Journal:  BMJ Open       Date:  2022-01-06       Impact factor: 3.006

5.  Visual Function, Physical Function, and Activities of Daily Living in Two Aging Communities.

Authors:  Xinxing Guo; Lubaina T Arsiwala; Yanan Dong; Aleksandra Mihailovic; Pradeep Y Ramulu; A Richey Sharrett; Thomas Mosley; Alison G Abraham
Journal:  Transl Vis Sci Technol       Date:  2021-12-01       Impact factor: 3.283

6.  Can the Geriatric Day Hospital Act As a Hub for Services for Older People across the Spectrum of Ageing from Active Ageing to Advanced Frailty?

Authors:  Rónán O'Caoimh; Siobhán Kennelly; Diamuid O'Shea
Journal:  Front Med (Lausanne)       Date:  2018-03-02

7.  Impact of the comprehensive geriatric assessment on treatment decision in geriatric oncology.

Authors:  Sandrine Sourdet; Delphine Brechemier; Zara Steinmeyer; Stephane Gerard; Laurent Balardy
Journal:  BMC Cancer       Date:  2020-05-06       Impact factor: 4.430

8.  Frailty and Different Exercise Interventions to Improve Gait Speed in Older Adults after Acute Coronary Syndrome.

Authors:  Aurelija Beigienė; Daiva Petruševičienė; Vitalija Barasaitė; Raimondas Kubilius; Jūratė Macijauskienė
Journal:  Medicina (Kaunas)       Date:  2021-12-09       Impact factor: 2.430

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.